IRIS
MERLINO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.128
EU - Europa 2.556
NA - Nord America 2.320
SA - Sud America 381
AF - Africa 79
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.470
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.245
SG - Singapore 1.250
RU - Federazione Russa 987
IT - Italia 873
CN - Cina 690
VN - Vietnam 614
BR - Brasile 298
HK - Hong Kong 186
DE - Germania 136
FR - Francia 111
NL - Olanda 100
GB - Regno Unito 86
FI - Finlandia 82
JP - Giappone 68
IN - India 66
IE - Irlanda 46
KR - Corea 46
BD - Bangladesh 45
AR - Argentina 40
CA - Canada 40
TH - Thailandia 26
PL - Polonia 24
SE - Svezia 23
CI - Costa d'Avorio 20
PK - Pakistan 19
ZA - Sudafrica 19
MX - Messico 18
PH - Filippine 18
IQ - Iraq 17
ES - Italia 16
TR - Turchia 14
TW - Taiwan 13
UA - Ucraina 13
ID - Indonesia 12
MA - Marocco 10
BE - Belgio 8
CL - Cile 8
CO - Colombia 7
MY - Malesia 7
AE - Emirati Arabi Uniti 6
AT - Austria 6
BG - Bulgaria 6
EC - Ecuador 6
LT - Lituania 6
PY - Paraguay 6
UZ - Uzbekistan 6
VE - Venezuela 6
EG - Egitto 5
JM - Giamaica 5
PA - Panama 5
PE - Perù 5
SA - Arabia Saudita 5
AU - Australia 4
GR - Grecia 4
JO - Giordania 4
BY - Bielorussia 3
CZ - Repubblica Ceca 3
ET - Etiopia 3
LV - Lettonia 3
MK - Macedonia 3
RO - Romania 3
SN - Senegal 3
TN - Tunisia 3
UY - Uruguay 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BW - Botswana 2
CH - Svizzera 2
DZ - Algeria 2
EE - Estonia 2
IL - Israele 2
LB - Libano 2
NP - Nepal 2
AD - Andorra 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
CR - Costa Rica 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
EU - Europa 1
GA - Gabon 1
GP - Guadalupe 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
KE - Kenya 1
KW - Kuwait 1
ME - Montenegro 1
MM - Myanmar 1
MU - Mauritius 1
MZ - Mozambico 1
NA - Namibia 1
NO - Norvegia 1
OM - Oman 1
PS - Palestinian Territory 1
Totale 8.458
Salva come PNG Salva come JPEG
Città #
Singapore 576
San Jose 399
Naples 274
Moscow 243
Ashburn 224
Beijing 213
Chandler 208
Hefei 201
Ho Chi Minh City 190
Hong Kong 171
Hanoi 120
Santa Clara 104
Dallas 90
Amsterdam 78
The Dalles 75
Los Angeles 71
Napoli 66
Lauterbourg 64
Tokyo 57
Munich 47
Millbury 46
Rome 41
Dong Ket 40
New York 39
São Paulo 35
Seoul 34
Des Moines 32
Redondo Beach 31
Boston 27
Milan 27
Turku 27
Buffalo 26
Nanjing 25
Da Nang 23
Princeton 21
Helsinki 20
Dublin 19
Lappeenranta 19
Lawrence 19
Warsaw 19
Bangkok 17
Frankfurt am Main 17
Haiphong 17
Chicago 16
Stockholm 16
Orem 15
Johannesburg 14
Seattle 14
Toronto 12
Atlanta 11
Brooklyn 11
Falkenstein 11
Kochi 11
Nuremberg 11
Biên Hòa 10
Council Bluffs 10
Denver 10
Lahore 10
London 10
Manchester 10
Chennai 9
Florence 9
Mexico City 9
Viterbo 9
Wilmington 9
Arce 8
Baghdad 8
Bagnoli Irpino 8
Belfast 8
Charlotte 8
Montreal 8
Mumbai 8
Nanchang 8
Ottawa 8
Phoenix 8
Poplar 8
Shanghai 8
Belo Horizonte 7
Düsseldorf 7
Fairfield 7
Pescopagano 7
Rio de Janeiro 7
Salerno 7
San Giorgio a Cremano 7
Ankara 6
Houston 6
Hải Dương 6
Kuala Selangor 6
Ninh Bình 6
Pittsburgh 6
Porto Alegre 6
Portsmouth 6
Pune 6
Quận Ba 6
Secaucus 6
Shenyang 6
Afragola 5
Augusta 5
Aversa 5
Brussels 5
Totale 4.576
Salva come PNG Salva come JPEG
Nome #
Functional Selectivity Revealed by N-Methylation Scanning of Human Urotensin II and Related Peptides 235
1H NMR-based metabolomics study on follicular fluid from patients with Polycystic Ovary Syndrome 220
Urokinase receptor derived peptides as potent inhibitors of the formyl peptide receptor type 1-triggered cell migration 201
Antimicrobial peptide Temporin-L complexed with anionic cyclodextrins results in a potent and safe agent against sessile bacteria 183
Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs 182
Unveiling the biological effects of DNA G-quadruplex ligands through multi-omics data integration 175
Microwave-Assisted Synthesis of 2-Methyl-1H-indole-3-carboxylate Derivatives via Pd-Catalyzed Heterocyclization 172
Cyclization of the urokinase receptor-derived Ser-Arg-Ser-Arg-Tyr peptide generates a potent inhibitor of trans-endothelial migration of monocytes 168
Discovery of Novel Potent and Selective Agonists at the Melanocortin-3 Receptor 166
Development and Nanoparticle-Mediated Delivery of Novel MDM2/MDM4 Heterodimer Peptide Inhibitors to Enhance 5-Fluorouracil Nucleolar Stress in Colorectal Cancer Cells 162
The Outcomes of Decorated Prolines in the Discovery of Antimicrobial Peptides from Temporin-L 161
Novel Antimicrobial Peptide from Temporin L in The Treatment of Staphylococcus pseudintermedius and Malassezia pachydermatis in Polymicrobial Inter-Kingdom Infection 157
Unveiling the mechanism of action of acylated temporin L analogues against multidrug-resistant Candida albicans 155
Discovery of New Potent Ligands at Human Urotensin-II Receptor 154
An investigation into the origin of the biased agonism associated with the urotensin II receptor activation 153
Antifungal and Antibiofilm Activity of Cyclic Temporin L Peptide Analogues against Albicans and Non-Albicans Candida Species 150
Intestinal anti-inflammatory effect of a peptide derived from gastrointestinal digestion of buffalo (Bubalus bubalis) mozzarella cheese 147
Unlocking the potential of protein-derived peptides to target G-quadruplex DNA: from recognition to anticancer activity 146
Glycine-replaced derivatives of [Pro3,DLeu9]TL, a temporin L analogue: Evaluation of antimicrobial, cytotoxic and hemolytic activities 146
Synthesis and Pharmacological Evaluation of a Novel Peptide Based on Anemonia sulcata BDS-I Toxin as a New KV3.4 Inhibitor Exerting a Neuroprotective Effect Against Amyloid-β Peptide 146
Temporin L-derived peptide as a regulator of the acute inflammatory response in zymosan-induced peritonitis 142
Urotensin II(4-11) Azasulfuryl Peptides: Synthesis and Biological Activity 141
Urotensin-II-Targeted Liposomes as a New Drug Delivery System towards Prostate and Colon Cancer Cells 141
Sensitization of melanoma cells to standard chemotherapy: G-quadruplex binders as synergistic agents 140
Lead Optimization of P5U and Urantide: Discovery of Novel Potent Ligands at the Urotensin-II Receptor 139
Disulfide bond replacement with 1,4‐ and 1,5‐disubstituted [1,2,3]‐triazole on C‐X‐C chemokine receptor type 4 (CXCR4) peptide ligands: small changes that make big differences 139
New biologic (Ab-IPL-IL-17) for IL-17-mediated diseases: identification of the bioactive sequence (nIL-17) for IL-17A/F function 138
Antimicrobial Activity of a Lipidated Temporin L Analogue against Carbapenemase-Producing Klebsiella pneumoniae Clinical Isolates 138
Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors 137
Synthetic Amphipathic β-Sheet Temporin-Derived Peptide with Dual Antibacterial and Anti-Inflammatory Activities 136
HOST DEFENSE TEMPORIN 1 PEPTIDES AND THEIR POTENTIAL AS ANTIVIRAL AGENTS 135
Novel α-MSH peptide analogues with broad spectrum antimicrobial activity. 131
Simultaneous Targeting of RGD-Integrins and Dual Murine Double Minute Proteins in Glioblastoma Multiforme 130
Breast tumor cell invasion and pro-invasive activity of cancer-associated fibroblasts co-targeted by novel urokinase-derived decapeptides 130
Structure-Activity Study of the Peptides P5U and Urantide by the Development of Analogues Containing Uncoded Amino Acids at Position9 129
New insight into the binding mode of peptides at urotensin-II receptor by Trp-constrained analogues of P5U and urantide. 127
First-in-Class Cyclic Temporin L Analogue: Design, Synthesis, and Antimicrobial Assessment 126
Glioblastoma Cell Migration, Invasion and Vasculogenic Mimicry Downmodulated by Novel uPAcyclin Derivatives 124
From a Helix to a Small Cycle: Metadynamics-Inspired αvβ6 Integrin Selective Ligands 124
Urotensin II receptor expression in patients with ulcerative colitis: a pilot study 124
Ad-hoc modifications of cyclic mimetics of SOCS1 protein: Structural and functional insights 122
Treatment with a Urokinase Receptor-derived Cyclized Peptide Improves Experimental Colitis by Preventing Monocyte Recruitment and Macrophage Polarization 121
Enhanced 5-FU-mediated activation of p53-dependent nucleolar stress by MDM2/4 peptide inhibitors in colon cancer cells 119
MDM2/4 inhibitors as novel therapeutic strategy to enhance 5-FU induced nucleolar stress and apoptosis in colon cancer cells 117
HOPPI-NMR: Hot-Peptide-Based Screening Assay for Inhibitors of Protein-Protein Interactions by NMR 116
Combination of 5-FU and MDM2/4 peptide inhibitors as a promising strategy to enhance 5-FU induced nucleolar stress. 115
DESIGN AND SYNTHESIS OF N-METHYL DERIVATIVES OF UROTENSIN-II 115
Boosting Fmoc Solid-Phase Peptide Synthesis by Ultrasonication 115
Urotensin-II Ligands: An Overview from Peptide to Nonpeptide Structures 114
Activation of Melanocortin Receptors MC1 and MC5 Attenuates Retinal Damage in Experimental Diabetic Retinopathy 114
Expanding Structure-Activity Relationships of Human Urotensin II Peptide Analogues: A Proposed Key Role of the N-Terminal Region for Novel Urotensin II Receptor Modulators 113
Unveiling the interaction between DNA G-quadruplexes and RG-rich peptides 113
Synthesis of temporin L hydroxamate-based peptides and evaluation of their coordination properties with iron (III) 108
Novel temporin L antimicrobial peptides: promoting self-assembling by lipidic tags to tackle superbugs 105
Novel anti-inflammatory and chondroprotective effects of the human melanocortin MC1 receptor agonist BMS-470539 dihydrochloride and human melanocortin MC3 receptor agonist PG-990 on lipopolysaccharide activated chondrocytes 103
null 98
ANALOGHI DELLA TEMPORINA L CON ATTIVITÀ ANTI-INFIAMMATORIA E ANTIMICROBICA 91
Strategic Single-Residue Substitution in the Antimicrobial Peptide Esc(1-21) Confers Activity against Staphylococcus aureus, Including Drug-Resistant and Biofilm Phenotype. 77
Ultrasound-assisted Peptide Nucleic Acids synthesis (US-PNAS) 75
The urotensin-II receptor: A marker for staging and steroid outcome prediction in ulcerative colitis 73
A Small CEACAM5 Peptide Restores the Protective Function of CD8+ Regulatory T Cells in Crohn's Disease 73
PEPTIDE AD ATTIVITÀ ANTIMICOTICA E ANTIBATTERICA 67
Disulfide bond replacement with non-reducible side chain to tail macrolactamization for the development of potent and selective CXCR4 peptide antagonists endowed with flanking binding sites 60
SIRT6 interacts with TRF2 and promotes its degradation in response to DNA damage 59
Sustainable Ultrasound-Assisted Solid-Phase peptide synthesis (SUS-SPPS): Less Waste, more efficiency 53
CheckMate 141 trial: all that glitters is not gold 52
Comprehensive structural investigation of a potent and selective CXCR4 antagonist via crosslink modification 44
αV-Integrin-Dependent Inhibition of Glioblastoma Cell Migration, Invasion and Vasculogenic Mimicry by the uPAcyclin Decapeptide 41
Urotensin-II Receptor: A Double Identity Receptor Involved in Vasoconstriction and in the Development of Digestive Tract Cancers and other Tumors 25
Design and evaluation of dual-functional aptamer-peptide conjugates as a platform for targeted cancer therapy 19
Probing Guanidino Pendant or Bridged Groups in Cyclic Antimicrobial Peptides Derived from Temporin L: A Strategy to Improve Efficacy against Gram-Negative Bacteria 4
Coupling PD-L1 Inhibition and Lysosomal Degradation: Innovative Anti-PD-L1 Peptides for NSCLC Immunotherapy 4
Structure-Guided Design of Temporin-Derived Peptides Reveals Potent Dual-Mechanism Inhibitors of SARS-CoV-2 1
Totale 8.676
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.708
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.708
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202157 0 0 0 0 0 0 0 0 0 0 12 45
2021/2022306 7 3 13 7 20 4 6 13 39 41 54 99
2022/2023578 44 32 27 43 74 72 12 62 95 75 29 13
2023/2024420 18 66 45 27 39 39 14 61 9 20 56 26
2024/20252.329 109 92 30 64 35 161 234 172 171 243 818 200
2025/20264.475 502 362 546 436 736 163 534 241 520 275 160 0
Totale 8.676